We are live on ! Find out more
PAHC icon

Phibro Animal Health

138 hedge funds and large institutions have $264M invested in Phibro Animal Health in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

404% more call options, than puts

Call options by funds: $136K | Put options by funds: $27K

21% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 14

9% more capital invested

Capital invested by funds: $242M → $264M (+$22M)

1% more funds holding

Funds holding: 136138 (+2)

2% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 47

2.44% less ownership

Funds ownership: 102.69%100.25% (-2.4%)

Holders
138
Holders Change
+2
Holders Change %
+1.47%
% of All Funds
1.99%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
48
Reduced
47
Closed
14
Calls
$136K
Puts
$27K
Net Calls
+$109K
Net Calls Change
+$145K
Name Holding Trade Value Shares
Change
Change in
Stake
Teacher Retirement System of Texas
76
Teacher Retirement System of Texas
Texas
$219K +$203K +16,932 New
Fidelity Investments
77
Fidelity Investments
Massachusetts
$216K +$95.5K +7,969 +92%
CIS
78
Connors Investor Services
Pennsylvania
$215K
JP Morgan Chase
79
JP Morgan Chase
New York
$214K -$1.02M -84,698 -84%
CCIA
80
Campbell & Co Investment Adviser
Maryland
$207K +$36.5K +3,046 +23%
NSEDCP
81
NJ State Employees Deferred Compensation Plan
New Jersey
$207K
Walleye Capital
82
Walleye Capital
New York
$203K -$61.3K -5,112 -25%
Canada Life
83
Canada Life
Manitoba, Canada
$200K
T. Rowe Price Associates
84
T. Rowe Price Associates
Maryland
$200K +$12.7K +1,063 +7%
Susquehanna International Group
85
Susquehanna International Group
Pennsylvania
$197K +$17.9K +1,491 +11%
WN
86
Williams & Novak
California
$196K
VIA
87
Virtus Investment Advisers
Connecticut
$191K -$95.9K -8,000 -35%
TRCT
88
Tower Research Capital (TRC)
New York
$187K +$75.5K +6,295 +77%
A
89
AlphaQuest
New York
$186K +$114K +9,526 +197%
Connor, Clark & Lunn Investment Management (CC&L)
90
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$182K +$169K +14,066 New
SOW
91
State of Wyoming
Wyoming
$180K +$42.2K +3,520 +34%
Deutsche Bank
92
Deutsche Bank
Germany
$165K -$12.8K -1,070 -8%
DM
93
Deerfield Management
New York
$161K +$149K +12,433 New
SOADOR
94
State of Alaska Department of Revenue
Alaska
$160K -$1.46K -122 -1%
MIM
95
MetLife Investment Management
New Jersey
$153K
IMRF
96
Illinois Municipal Retirement Fund
Illinois
$148K +$9.17K +765 +7%
DAS
97
Dynamic Advisor Solutions
Arizona
$145K -$86.2K -7,195 -39%
Cerity Partners
98
Cerity Partners
New York
$143K +$133K +11,094 New
AIG
99
American International Group
New York
$143K -$1.19K -99 -0.9%
CC
100
Centiva Capital
New York
$140K -$83.2K -6,945 -39%

PAHC Hedge Fund Activity: Q1 2024 in Review

138 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q1 2024, worth a combined $264M — up 9.1% from $242M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new PAHC positions and 14 closed out — a net gain of 3 holders — while 48 added to existing stakes and 47 trimmed.

The largest buyer was Dana Investment Advisors, opening a new position worth an estimated $5.25M. The largest seller was Millennium Management, cutting an estimated $6.12M.

  • 138 institutional investors held Phibro Animal Health (PAHC) as of Q1 2024, up from 136 in Q4 2023.
  • Funds reported $264M of Phibro Animal Health stock for Q1 2024, up 9.1% quarter-over-quarter.
  • 17 funds opened new Phibro Animal Health positions in Q1 2024 and 14 closed out, a net change of +3 holders.
  • The largest Phibro Animal Health buyer in Q1 2024 was Dana Investment Advisors, an estimated $5.25M added.
  • The largest Phibro Animal Health seller in Q1 2024 was Millennium Management, an estimated $6.12M sold.

Based on aggregated 13F filings for Q1 2024.